Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

17 results about "Dialysis Therapy" patented technology

Continuous renal replacement therapy hemodialysis or hemofiltration done 24 hours a day for an extended period, usually in a critically ill patient. convulsive therapy treatment of mental disorders, primarily depression, by induction of convulsions.

Device and method for the production of permeate, in particular for dialysis therapy

A water treatment plant or system for the production of permeate includes a reverse osmosis stage and a permeate stage. The reverse osmosis stage can include a piping system having a supply line for process input water, a reverse osmosis pump, and a reverse osmosis tank. The reverse osmosis tank has an inlet for process input water coming from the reverse osmosis pump, a membrane, and an outlet for permeate. The permeate stage, which can have a line system forming a circuit, can include a permeate tank, a permeate pump, and a tapping point for connecting at least one consumer or user of permeate. The reverse osmosis stage and the permeate stage can be connected to one another via a connecting line in such a way that the reverse osmosis stage feeds the permeate stage with permeate. The circuit of the permeate stage can include a sterile filter.
Owner:B BRAUN AVITUM

Device and method for the production of permeate, in particular for dialysis therapy

Main requirement: Water treatment plant for the production of permeate, especially for dialysis therapy, comprising • a reverse osmosis stage (137) with a piping system comprising a supply line (131) for process inlet water (100), a reverse osmosis pump (103) and a reverse osmosis tank (130), wherein the reverse osmosis tank (130) has an inlet (143) for the process inlet water (100) coming from the reverse osmosis pump (103), a membrane (104) and an outlet (144) for permeate (108), • a permeate stage (139) with a circulating piping system comprising a permeate tank (112), a permeate pump (114) and a take-off point (134) for connecting at least one consumer or user of permeate (108), wherein the reverse osmosis stage (137) and the permeate stage (139) are connected to each other via a connecting line (138) such that the reverse osmosis stage (137) feeds the permeate stage (139) with permeate (108), and wherein the circuit of the permeate stage (138) comprises a sterile filter (116).
Owner:B BRAUN AVITUM

Therapy prediction and optimization for renal failure blood therapy

A renal failure blood therapy system includes a memory device storing a therapy target for a patient. The system also includes a processor configured to receive the therapy target for the patient, receive a desired solute concentration for the patient, and apply the therapy target and the desired solute concentration as inputs to an optimization routine. The processor is also configured to execute the optimization routine to determine at least one dialysis therapy prescription specifying at least a dialysis therapy duration, a dialysis therapy frequency, and at least one of a dialysis therapy blood flow rate or a dialysis therapy dialysate flow rate. The processor is further configured to display the at least one dialysis therapy prescription for confirmation or selection by a clinician and transmit the selected or confirmed dialysis therapy prescription to a dialysis machine for a subsequent dialysis treatment for the patient.
Owner:VANTIVE HEALTH GMBH +1

Disinfection of systems for generating treatment fluid for use in dialysis

A system is configured to provide treatment fluid for use in dialysis therapy. A first sub-system (30) provides a flow of product water in a circulation path (34). A second sub-system (10) is fluidly connected to the circulation path on first and second connecting paths (CP1, CP2) and is operable to generate treatment fluid by use of product water. In a disinfection mode of the system, the second sub-system obtains product water on the first or second connecting path, produces a disinfection fluid based on the product water, and performs a disinfection of at least part of the second sub-system by use of the disinfection fluid. As part of the disinfection mode, the second sub-system generates a throughflow of disinfection fluid in the first and second connecting paths and in the circulation path between the first and second connecting paths, allowing the second sub-system to be disinfected separately from the first sub-system.
Owner:GAMBRO LUNDIA AB

System and method for supplying a fluid for use in dialysis therapy

PCT designated stageWO2026012933A1Medical devicesPeritoneal dialysisMedicineDialysis Therapy
An arrangement is provided for supplying a fluid for use in dialysis therapy. The arrangement comprises a vessel (10) for holding the fluid, an inlet line (L1) for directing the fluid to an inlet port (10a) on the vessel, an electrical heating device (12) for heating the fluid in the vessel, and a supply line (L2) for directing the fluid from an outlet port (10b) of the vessel. A fluid pump (P1) is arranged to achieve a flow of the fluid along the inlet line, through the vessel, and along the supply line. A heat exchanger (14) is arranged to transfer heat between the inlet line and the supply line, and a heat pump (15), for example thermoelectric, is operable to transfer heat between the inlet line and the supply line. A control device (30) operates the heat pump so as to achieve a target temperature of the fluid in the supply line, downstream of the heat exchanger and the second location.
Owner:GAMBRO LUNDIA AB

System for inline production of peritoneal dialysis fluid

PendingUS20260034288A1Medical devicesPeritoneal dialysisPoint of careNursing care
Systems, components, and methods are provided for a flexible, efficient system capable of producing customized dialysis fluid at the point of care. By enabling precise control over the solution's composition, the system significantly the customization, safety, and effectiveness of dialysis therapy. The placement of sensors and feedback mechanisms ensures accurate monitoring and adjustment of the solution's composition for dialysis fluid for patient treatment.
Owner:MOZARC MEDICAL US LLC

Device and method for producing permeate, in particular for dialysis therapy

Main claim: Water treatment plant for the production of permeate, in particular for dialysis therapy, comprising: • a reverse osmosis stage (137) with a piping system comprising a supply line (131) for process inlet water (100), a reverse osmosis pump (103) and a reverse osmosis tank (130), wherein the reverse osmosis tank (130) has an inlet (143) for the process inlet water (100) coming from the reverse osmosis pump (103), a membrane (104) and an outlet (144) for permeate (108), • a permeate stage (139) with a circulating piping system comprising a permeate tank (112), a permeate pump (114) and a discharge point (134) for connecting at least one consumer or user of permeate (108), wherein the reverse osmosis stage (137) and the permeate stage (139) are connected to each other via a connecting line (138) such that the reverse osmosis stage (137) feeds the permeate stage (139) with permeate (108),and wherein the permeate stage circuit (138) includes a sterile filter (116).
Owner:B BRAUN AVITUM

Handling waste fluid generated during dialysis therapy

An apparatus is provided for handling waste fluid, WF, generated in connection with dialysis therapy, to mitigate the risk that a patient undergoing dialysis therapy is exposed to harmful leakage currents. The apparatus includes a fluid disposal arrangement, FDA (40), which is configured to receive WF and define a fluid flow path (41) for directing WF to a drain. The FDA (40) is operable to combine WF with a dilution fluid, DF, at a supply region (44) in the fluid flow path (41). A control arrangement (50) is configured to operate one or more flow controllers (42, 45) in the FDA (40) to relatively control a first fluid flow of DF and a second fluid flow of WF into the supply region (44) so that a hypothetical homogeneous mixture of DF and WF at the supply region (44) has an electrical conductivity below a first limit value.
Owner:GAMBRO LUNDIA AB

Single needle dialysis system and methods

PendingUS20260248989A1Tap waterIntensive care medicine
Dialysis systems and methods are described which can include a number of features. The dialysis systems described can be to provide dialysis therapy to a patient in the comfort of their own home. The dialysis system can be configured to prepare purified water from a tap water source in real-time that is used for creating a dialysate solution. The dialysis systems described also include features that make it easy for a patient to self-administer therapy.
Owner:OUTSET MEDICAL

Dialysis system and methods

Dialysis systems and methods are described which can include a number of features. The dialysis systems described can be to provide dialysis therapy to a patient in the comfort of their own home. The dialysis system can be configured to prepare purified water from a tap water source in real-time that is used for creating a dialysate solution. The dialysis systems described also include features that make it easy for a patient to self-administer therapy.
Owner:OUTSET MEDICAL

System for inline production of peritoneal dialysis fluid

PCT designated stageWO2026030600A1Medical devicesPeritoneal dialysisPoint of careNursing care
Systems, components, and methods are provided for a flexible, efficient system capable of producing customized dialysis fluid at the point of care. By enabling precise control over the solution's composition, the system significantly the customization, safety, and effectiveness of dialysis therapy. The placement of sensors and feedback mechanisms ensures accurate monitoring and adjustment of the solution's composition for dialysis fluid for patient treatment.
Owner:MOZARC MEDICAL US LLC

Generating treatment fluid for use in dialysis therapy

PCT designated stageWO2026099150A1Medical devicesPeritoneal dialysisIntensive care medicineDialysis Therapy
A system is configured to generate treatment fluid for use in dialysis by mixing water with one or more liquid concentrates (Cx). The system comprises a fluid path arrangement (L), an input port arrangement in fluid communication with the fluid path arrangement, and a heater (9). The input port arrangement is configured for releasable connection to a set of containers (7) holding the one or more liquid concentrates. The system is operated to perform time-separated sessions of generating treatment fluid. The system is further operated, between the sessions and by use of the heater (9), to perform a first heat disinfection of the fluid path arrangement except for a subset thereof. The system is further operated to arrange at least one of the one or more liquid concentrates in the subset between the time-separated sessions.
Owner:GAMBRO LUNDIA AB

Devices for handling leakage currents in dialysis therapy

An apparatus (100) for use in dialysis therapy, said apparatus comprising: a fluid handling unit (110) configured to interact with fluid communicating between a first fluid interface (131) and a second fluid interface (132); 5 power circuitry (120) connected to the fluid handling unit, said power circuitry including: a primary power inlet (121) connected via a primary circuit to the fluid handling unit; a secondary power inlet (122) connected via a secondary circuit to the fluid 0 handling unit; and a relay circuit (123) configured to disconnect the primary circuit based on voltage being received in the secondary power inlet.
Owner:GAMBRO LUNDIA AB

Power management for dialysis therapy in a residential space

A control device performs a method for power management in relation to a dialysis system installed in a residential space. In the method, the dialysis system is operated to perform a heat disinfection procedure, HDP, in preparation of dialysis therapy. During the HDP, power measurement data representing a momentary power consumption in the residential space is obtained (203). A projected power consumption in the residential space at one or more future time points is determined based on the power measurement data (204). The projected power consumption is evaluated in relation to a maximum limit of power consumption in the residential space, for detection of an upcoming power shortage (205). To counteract the upcoming power shortage, the HDP and / or an operation of at least one electrical device other that the dialysis system in the residential space is modified (206).
Owner:GAMBRO LUNDIA AB

Total organic carbon measurement system

A system for performing dialysis therapy includes a first conduit, an inlet sensor configured to sense a first property of a fluid, a flow cell device configured to oxidize the fluid, a second conduit, and an outlet sensor configure to sense a second property of the fluid. The sensed first property and second property can be used to determine a total organic carbon of the fluid. The flow cell device includes a housing including a fluid inlet configured to receive the fluid, a fluid outlet configured to output the fluid, a first chamber fluidly connected to the fluid inlet and outlet, and an energy source that outputs energy to the fluid passing through the first chamber. The flow cell can include a second chamber fluidly separated from and disposed within the first chamber, and the energy source can be disposed within the second chamber.
Owner:MOZARC MEDICAL US LLC